Indivior Pharmaceuticals, Inc.

INDV·NASDAQ·$37.81Share Price as of 11/2·$5BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/29/26 10-QQ2 ended 06/30/2608/03/26 10-QQ1 ended 03/31/2604/30/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2510/30/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report10/15/26 8-KCurrent report10/06/26 8-KCurrent report09/17/26 8-KCurrent report09/15/26

Prospectuses and Registrations

424B3Prospectus09/11/26 S-4/ARegistration (business combination, amended)09/09/26 S-4Registration (business combination)08/28/26 S-8Registration of securities for employees01/26/26 S-8 POSPost-effective amendment (S-8)01/26/26

Proxies

DEF 14ADefinitive proxy03/27/26 DEFA14AAdditional proxy materials03/27/26 DFAN14AAdditional materials (non-management)02/16/23 DFAN14AAdditional materials (non-management)02/06/23 DFAN14AAdditional materials (non-management)12/20/22

Ownership

SC 13GBeneficial ownership09/30/26 Form 4Insider transaction08/27/26 SC 13D/ABeneficial ownership (amended)08/13/26 Form 4Insider transaction08/05/26 Form 4Insider transaction07/13/26

Other

42542510/29/26 42542510/06/26 42542509/17/26 EFFECTRequest for effectiveness09/11/26 42542508/04/26